McGill University: Small Doses Of Lithium May Stop Alzheimer’s In Its Tracks
In a new study by McGill University, researchers found that small doses of Lithium may stop Alzheimer's, according to SciTechDaily.
In the study, researchers found that small doses of Lithium, sometimes 400x lower than a typical prescription, are linked to halting signs of advanced Alzheimer’s pathology such as amyloid plaques and recovering lost cognitive abilities.
Lithium treatments are considered impractical in many scenarios due to the severe side effects that can result if used for long periods of time, but this study might change that outlook. The amount of lithium used in this study is less than the amount in drugs that regulate mood disorders.
Dr. Claudio Cuello led the study and stated, "microdoses of lithium at concentrations hundreds of times lower than applied in the clinic for mood disorders were administered at early amyloid pathology stages in the Alzheimer’s-like transgenic rat. These results were remarkably positive and were published in 2017 in Translational Psychiatry and they stimulated us to continue working with this approach on a more advanced pathology.”
A team of researchers at McGill University found that small doses of lithium can halt signs of Alzheimer's and recover lost cognitive abilities.